Florian Klein
Impact in
- Virology top 0.05%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
- Virology 72
- HIV Research and Treatment 71
-
- SARS-CoV-2 and COVID-19 Research 48
- SARS-CoV-2 detection and testing 17
- COVID-19 Clinical Research Studies 10
- Co-authors
- Michel C. Nussenzweig (29 shared papers)Michael S. Seaman (17 shared papers)Johannes F. Scheid (12 shared papers)Pamela J. Björkman (12 shared papers)Henning Gruell (43 shared papers)Hugo Mouquet (7 shared papers)Anthony P. West (8 shared papers)Louise Scharf (4 shared papers)
- Journals
- Nature Medicine (10 papers)Nature (9 papers)The Journal of Experimental Medicine (9 papers)Cell (9 papers)Proceedings of the National Academy of Sciences (7 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Florian Klein
191 papers receiving 15.1k citations
Florian Klein's Hit Papers
Peers
Comparison fields: 5 of 135
- Virology 8.4k
- Infectious Diseases 3k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Immunology 892
- Neurology 543
Countries citing papers authored by Florian Klein
This map shows the geographic impact of Florian Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Klein more than expected).
Fields of papers citing papers by Florian Klein
This network shows the impact of papers produced by Florian Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Klein. The network helps show where Florian Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding Hit paper breakdown → | 2011 | 997 |
| 2 | Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 Hit paper breakdown → | 2015 | 655 |
| 3 | Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys Hit paper breakdown → | 2013 | 549 |
| 4 | Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study Hit paper breakdown → | 2021 | 532 |
| 5 | 2013 | 439 | |
| 6 | HIV therapy by a combination of broadly neutralizing antibodies in humanized mice Hit paper breakdown → | 2012 | 438 |
| 7 | Combination therapy with anti-HIV-1 antibodies maintains viral suppression Hit paper breakdown → | 2018 | 422 |
| 8 | Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity Hit paper breakdown → | 2014 | 421 |
| 9 | HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption Hit paper breakdown → | 2016 | 408 |
| 10 | 2013 | 405 | |
| 11 | Antibody 10-1074 suppresses viremia in HIV-1-infected individuals Hit paper breakdown → | 2017 | 401 |
| 12 | 2013 | 384 | |
| 13 | HIV-1 Integration Landscape during Latent and Active Infection Hit paper breakdown → | 2015 | 379 |
| 14 | 2014 | 334 | |
| 15 | 2011 | 331 | |
| 16 | mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant Hit paper breakdown → | 2022 | 328 |
| 17 | Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study Hit paper breakdown → | 2021 | 290 |
| 18 | 2014 | 285 | |
| 19 | 2014 | 280 | |
| 20 | 2016 | 274 |
About Florian Klein
Florian Klein is a scholar working on Virology, Infectious Diseases, Modeling and Simulation, Hematology and Public Health, Environmental and Occupational Health, having authored 199 papers that have together received 15.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (71 papers), SARS-CoV-2 and COVID-19 Research (48 papers), SARS-CoV-2 detection and testing (17 papers), COVID-19 Clinical Research Studies (10 papers), Acute Lymphoblastic Leukemia research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), COVID-19 epidemiological studies (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Virology (8.4k citations), Infectious Diseases (3k citations), Radiology, Nuclear Medicine and Imaging (1.2k citations), Immunology (892 citations) and Neurology (543 citations). Florian Klein has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Michel C. Nussenzweig, Michael S. Seaman, Johannes F. Scheid, Pamela J. Björkman, Henning Gruell, Hugo Mouquet, Anthony P. West, Louise Scharf, Marina F. Caskey and Clara Lehmann. Their work appears in journals such as Nature Medicine, Nature, The Journal of Experimental Medicine, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.